Serradimigni A, Jouve R, Spriet A
J Mal Vasc. 1985;10(2):108-16.
The effectiveness of drugs to improve the walking distance in intermittent claudication patients is looked into five points: pathophysiology, drugs, methodology of clinical trials, sample survey among the members of the hemodynamic section of the French College of Vascular Diseases and biometric aspects. Finally, some important points of a clinical trial in this field are presented.
病理生理学、药物、临床试验方法、法国血管病学院血液动力学分会成员的样本调查以及生物统计学方面。最后，介绍了该领域一项临床试验的一些要点。
